HomeMedical SpecialtiesMental HealthLargest donation ever for mental health will bring hope to all Canadians

Largest donation ever for mental health will bring hope to all Canadians

Published on

Mental illness is the world’s leading cause of disability, affecting more than 6.7 million Canadians.  The Centre for Addiction and Mental Health (CAMH) is honoured to be entrusted with the first $100 million donation in Canada dedicated to defining the causes of mental illness and to developing the cures that will save lives and create hope. It’s an anonymous gift to Canada’s largest mental health academic health science centre, given in the spirit of public service and intended to fuel the discovery that will save lives and create social change for all Canadians.

“Complex problems need complex solutions. We need to invest in the fundamental research and the clinical innovation that will improve the health of individuals and populations, locally, nationally and globally. This gift will make that a reality,” says Dr. Catherine Zahn, CAMH President and CEO.

MORE: NURSES HELPING BREAKDOWN BARRIERS TO HEALTHCARE

This investment will create a Discovery Fund, which will allow CAMH to accelerate its efforts to transform the lives of people who live with mental illness. The Discovery Fund will enable CAMH to attract talent, explore big ideas, support young scientists and leverage data to expose the mysteries of the brain.

“I believe CAMH is well-positioned to make a transformational impact in the field of mental health research. I have seen the devastating impact of mental illness on individuals and their families; I want to provide support to the next generation of researchers and scientists to pursue the research that will directly transform care. In order to enable quantum leaps forward, this gift will also support high-risk, high-reward research,” said the donor.

“We are eternally grateful to this donor, for investing $100 million in our capacity to generate world-leading clinical discovery, and to invest in some of the high-risk, high-reward research that usually doesn’t get top funding priority,” says Darrell Louise Gregersen, President & CEO, CAMH Foundation. “Philanthropy at CAMH is truly changing the future of mental illness, and creating hope for all Canadians.”

The Discovery Fund will enable CAMH to make remarkable breakthroughs in a number of priority areas:

  • People Development: Incubate and activate the next generation of leading early and mid-career scientists.
  • New Ideas: Foster discovery and innovation that is focused on understanding disease mechanisms, effective diagnosis, testing; and new ways to predict, prevent and recover from mental illness.
  • Discovery Platform: Invest in enhancing the data, data platforms and analytics that will enable 21st Century research and translation of research findings into clinical practice.

The Discovery Fund will powerfully fuel CAMH’s capacity to address the challenges of diagnosis, prevention and treatment of mental illness. The Fund will accelerate research at CAMH and beyond, and transform the future of mental health care nationally and internationally.

For more information about applying to one of the fund programs, please visit: camh.ca/discoveryfund

To see a video featuring emerging CAMH scientists talking about how this fund could change the future of mental health, click here

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

Canada's doctors are concerned that false health information and disconnected health systems are putting...

More like this

Martha Tripicio – Nursing Hero

Humber River Health t is with profound respect and admiration that I nominate Martha Tripicio...

Catherine Bergman – Nursing Hero

University Health Network Catherine Bergman is recognized at Toronto General Hospital for her clinical expertise,...

Iryna Fedoryak – Nursing Hero

Sunnybrook Health Sciences Centre (St. John’s Rehab) We are honoured to nominate Iryna Fedoryak for...

Domino Puson – Nursing Hero

Trillium Health Partners We are honoured to nominate Domino Puson for the 21st Annual Hospital...

Susan Davidson 3rd Place Nursing Hero

Unity Health (St. Joseph’s Health Centre) am honored to nominate Susan Davidson for the Nursing...

Rodolfo D. Lastimosa Jr. 2nd Place Nursing Hero

Southbridge Care Homes am honored to nominate Rodolfo D. Lastimosa Jr. for the Nursing Hero...